Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-24 @ 10:40 PM
NCT ID:
NCT04380935
Eligibility Criteria:
Inclusion Criteria:
* Patients aged more than equal to 18 years.
* COVID-19 confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR)
* Having severe pneumonia.
* PAO2 / FIO2 \<300.
Exclusion Criteria:
* Contraindication to blood transfusions (fluid overload, history of anaphylaxis of blood products)
* Multiple and severe organ failure, hemodynamically unstable
* Other uncontrolled infections
* Disseminated intravascular coagulation (DIC) which requires a replacement factor/FFP
* Hemodialysis patients or CRRT (continuous renal replacement therapy)
* Active intracranial bleeding
* Significant myocardial ischemia
* Receiving tocilizumab treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04380935
Study Brief:
Protocol Section:
NCT04380935